European Journal of Clinical Pharmacology

, Volume 44, Issue 4, pp 319–323 | Cite as

Analgesic effect and plasma concentrations of codeine and morphine after two dose levels of codeine following oral surgery

  • H. Quiding
  • G. Lundqvist
  • L. O. Boréus
  • U. Bondesson
  • J. Öhrvik


A double blind randomised cross over investigation was carried out in 25 male patients undergoing two oral surgical extractions, one for each lower wisdom tooth. The two extractions were performed about 6 weeks apart and were carried out under local anaesthesia. One hour after each extraction the patients randomly received 90 or 45 mg codeine. During the following 5 h the patients rated the intensity of their pain on a visual analogue scale. Blood was simultaneously sampled and assayed for codeine and its metabolite morphine.

Mean pain intensity difference was just significantly higher after 90 mg codeine compared to 45 mg. The mean plasma concentrations of codeine and morphine were significantly higher after the 90 mg dose. However, for the two dose levels of codeine there was no obvious relationship between the difference in analgesic effect and the difference in the plasma concentration of codeine or morphine. The plasma concentrations of morphine were 2–3% of those of codeine and the levels were relatively low. Local formation of morphine from codeine within the human brain should therefore be investigated.

Four patients were unable to demethylate codeine to a detectable plasma concentration of morphine after 90 mg codeine. In those patients the analgesic effect during the first hours was better after 90 mg codeine than after 45 mg.

This suggests some analgesic effect of codeine itself.

Key words

Codeine Morphine analgesic effect plasma concentration oral administration 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Forsgren H, Heimdahl A, Johansson B, Krekmanov L (1985) Effect of application of cold dressings on the postoperative course in oral surgery. Int J Oral Surg 14: 223–228Google Scholar
  2. 2.
    McQuay HJ, Caroll D, Watts PG, Juniper RP, Moore RA (1989) Codeine 20 mg increases pain relief from ibuprofen 400 mg after third molar surgery. A repeat-dosing comparison of ibuprofen and an ibuprofen-codeine combination. Pain 37: 7–13Google Scholar
  3. 3.
    Findlay JWA, Butz RF, Welch RM (1977) Codeine kinetics as determined by radioimmunoassay. Clin Pharmacol Ther 22: 439–446Google Scholar
  4. 4.
    Findlay JWA, Jones EC, Butz RF, Welch RM (1978) Plasma codeine and morphine concentrations after therapeutic oral doses of codeine-containing analgesics. Clin Pharmacol Ther 24: 60–68Google Scholar
  5. 5.
    Rogers JF, Findlay JWA, Hull JH, Butz RF, Jones EC, Bustrack JA, Welch RM (1982) Codeine disposition in smokers and non-smokers. Clin Pharmacol Ther 32: 218–227Google Scholar
  6. 6.
    Quiding H, Anderson P, Bondesson U, Boréus LO, Hynning PÅ (1986) Plasma concentrations of codeine and its metabolite, morphine, after single and repeated oral administration. Eur J Clin Pharmacol 30: 673–677Google Scholar
  7. 7.
    Guay DRP, Awni WM, Halstenson CE, Findlay JWA, Opsahl JA, Abraham PA, Jones EC, Matzke GR (1987) Pharmacokinetics of codeine after single and multiple-oral-dose administration to normal volunteers. J Clin Pharmacol 27: 983–987Google Scholar
  8. 8.
    Persson K, Hammarlund-Udenaes M, Mortimer Ö, Rane A (1992) The postoperative pharmacokinetics of codeine. Eur J Clin Pharmacol 42: 663–666Google Scholar
  9. 9.
    Yue QY, Hasselström J, Svensson JO, Säwe J (1991) Pharmacokinetics of codeine and its metabolites in caucasian healthy volunteers: comparisons between extensive and poor hydroxylators of debrisoquine. Br J Clin Pharmacol 31: 635–642Google Scholar
  10. 10.
    Sanfilippo G (1948) Contributo sperimentale all'ipotesi della smetilazione della codeina nell'organismo. I. Influenze della dose sull'assuefazione alla codeina. II. Assuefazione alla codeina attenuta con somministrazione prolungata di morfina. Boll Soc Ital Biol Sper 24: 723–726Google Scholar
  11. 11.
    Dayer P, Desmeules J, Leemann T, Striberni R (1988) Bioactivation of the narcotic drug codeine in human liver is mediated by the polymorphic monooxygenase catalyzing debrisoquine 4-hydroxylation (cytochrome P-450 dbl/bufI). Biochem Biophys Res Comm 152: 411–416Google Scholar
  12. 12.
    Chen ZR, Somogyi AA, Bochner F (1988) Polymorphic O-demethylation of codeine. Lancet, II, 914–915Google Scholar
  13. 13.
    Yue QY, Swensson JO, Alm C, Sjöqvist F, Säwe J (1989) Codeine O-demethylation co-segregates with polymorphic debrisoquine hydroxylation. Br J Clin Pharmacol 28: 639–645Google Scholar
  14. 14.
    Mortimer Ö, Persson K, Ladona MG, Spalding D, Zanger UM, Meyer UA and Rane A (1990) Polymorphic formation of morphine from codeine in poor and extensive metabolizers of dextromethorphan: relationship to the presence of immunoidentified cytochrome P45OIIDI. Clin Pharmacol Ther 47: 27–35Google Scholar
  15. 15.
    Jones B, Kenward MG (1989) Design and analysis of cross-over trials. Chapman & Hall, New YorkGoogle Scholar
  16. 16.
    Fleiss JL (1986) The design and analysis of clinical experiments. Wiley & Sons, New YorkGoogle Scholar
  17. 17.
    Shah JC, Mason WD (1990) Plasma codeine and morphine concentrations after single oral dose of codeine phosphate. J Clin Pharmacol 30: 764–766Google Scholar
  18. 18.
    Quiding H, Olsson GL, Boréus LO, Bondesson U (1992) Infants and young children metabolise codeine to morphine. A study after single and repeated rectal administration. Br J Clin Pharmacol 33: 45–49Google Scholar
  19. 19.
    Dahlström B, Tamsen A, Paalzow L, Hartvig P (1982) Patient-controlled analgesic therapy: IV. Pharmacokinetics and analgesic plasma concentrations of morphine. Clin Pharmacokinet 7: 266–279Google Scholar
  20. 20.
    Säwe J, Dahlström B, Rane A (1983) Steady-state kinetics and analgesic effect of oral mophine in cancer patients. Eur J Clin Pharmacol 24: 537–542Google Scholar
  21. 21.
    Vater M, Smith G, Atherne GW, Aitkenhead AR (1984) Pharmacokinetics and analgesic effect of slow-release oral morphine in cancer patients. Br J Anaesth 56: 821–827Google Scholar
  22. 22.
    Sindrup SH, Brøsen K, Bjerring P, Arendt-Nielsen L, Larsen U, Angelo H, Gram LF (1991) Codeine increases pain thresholds to copper vapor laser stimuli in extensive but not poor metabolizers of sparteine. Clin Pharmacol Ther 49: 686–694Google Scholar
  23. 23.
    Chen ZR, Irvine RJ, Bochner F, Somogui AA (1990) Morphine formation from codeine in rat brain: a possible mechanism of codeine analgesia. Life Sci 46: 1067–1074Google Scholar
  24. 24.
    Osborne R, Joel S, Trew D, Slevin M (1988) Analgesic activity of morphine-6-glucuronide. Lancet I: 828Google Scholar
  25. 25.
    Hanna MH, Peat SJ, Woodham M, Knibb A, Fung C (1990) Analgesic efficacy and CSF pharmacokinetics of intrathecal morphine-6-glucuronide: comparison with morphine. Br J Anaesth 64: 547–550Google Scholar
  26. 26.
    Alvan G, Bechtel P, Iselius L, Gundert-Remy U (1990) Hydroxylation polymorphisms of debrisoquine and mephenytion in European populations. Eur J Clin Pharmacol 39: 533–537Google Scholar
  27. 27.
    Desmeules J, Gascon MP, Dayer P, Magistris M (1991) Impact of environmental and genetic factors on codeine analgesia. Eur J Clin Pharmacol 41: 23–26Google Scholar
  28. 28.
    Sindrup SH, Arendt-Nielsen L, Brøsen K, Bjerring P, Angelo HR, Eriksen B, Gram LF (1992) The effect of quinidine on the analgesic effect of codeine. Eur J Clin Phrmacol 42: 587–592Google Scholar

Copyright information

© Springer-Verlag 1993

Authors and Affiliations

  • H. Quiding
    • 1
  • G. Lundqvist
    • 2
  • L. O. Boréus
    • 1
  • U. Bondesson
    • 1
  • J. Öhrvik
    • 3
  1. 1.Department of Clinical PharmacologyKarolinska HospitalStockholmSweden
  2. 2.Department of Oral SurgeryKarolinska InstituteHuddingeSweden
  3. 3.Department of StatisticsThe Swedish University of Agricultural SciencesUppsalaSweden

Personalised recommendations